Results for tag: "Biogeneric"

The biogeneric market is a subset of the biopharmaceutical industry that focuses on the development and production of generic versions of biopharmaceuticals. Biogenerics are typically produced using biotechnological processes, such as recombinant DNA technology, and are designed to be therapeutically equivalent to the original biopharmaceutical. The biogeneric market is driven by the need to reduce healthcare costs and increase access to biopharmaceuticals. Biogeneric companies are typically small to medium-sized enterprises that specialize in the development and production of biogenerics. These companies often partner with larger pharmaceutical companies to gain access to the necessary resources and expertise. Examples of biogeneric companies include Amgen, Biocon, Cipla, Dr. Reddy's Laboratories, and Mylan. Show Less Read more